Literature DB >> 16950800

Polymorphisms in the MTHFR and VDR genes and skin cancer risk.

Jiali Han1, Graham A Colditz, David J Hunter.   

Abstract

Folate and vitamin D have been shown to be influenced by ultraviolet (UV) radiation. UVA radiation can break down plasma folate, whereas vitamin D can be synthesized in UVB-exposed skin. Folate metabolism is involved in DNA synthesis and repair, and vitamin D processes anti-proliferative effects. The functions of both nutrients are implicated in skin carcinogenesis. We evaluated genetic polymorphisms in the methylenetetrahydrofolate reductase (MTHFR) gene (C677T and A1298C) and the vitamin D receptor (VDR) gene (Fok1, Bsm1 and Cdx2) with skin cancer risk in a nested case-control study within the Nurses' Health Study [219 melanoma, 286 squamous cell carcinoma (SCC), 300 basal cell carcinoma (BCC) and 873 controls]. No significant associations were observed for the two MTHFR polymorphisms on skin cancer risk. We observed an interaction between the C677T polymorphism and total folate intake on SCC risk (P, interaction=0.04); the highest risk was observed among women with TT genotype and low folate intake (OR=2.14; 95% CI=1.01-4.50). The VDR Bsm1 BB genotype was significantly associated with an increased SCC risk (OR=1.51; 95% CI=1.00-2.28). An interaction between the Bsm1 polymorphism and total vitamin D intake on SCC was observed, with the highest risk seen in women with the BB genotype and high vitamin D intake (OR=2.38; 95% CI=1.22-4.62) (P, interaction=0.08). This study suggests a possible role of the polymorphisms in MTHFR and VDR interacting with dietary intakes of folate and vitamin D in skin cancer development, especially for SCC. Due to a large number of comparisons and tests, the possible associations should be interpreted with caution and confirmed by other studies.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16950800     DOI: 10.1093/carcin/bgl156

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  34 in total

Review 1.  New vitamin D analogs as potential therapeutics in melanoma.

Authors:  Paulina Szyszka; Michal A Zmijewski; Andrzej T Slominski
Journal:  Expert Rev Anticancer Ther       Date:  2012-05       Impact factor: 4.512

Review 2.  Systematic review and meta-analysis on vitamin D receptor polymorphisms and cancer risk.

Authors:  Yeqiong Xu; Bangshun He; Yuqin Pan; Qiwen Deng; Huiling Sun; Rui Li; Tianyi Gao; Guoqi Song; Shukui Wang
Journal:  Tumour Biol       Date:  2014-01-10

3.  From the bench to emerging new clinical concepts: Our present understanding of the importance of the vitamin D endocrine system (VDES) for skin cancer.

Authors:  Léa Trémezaygues; Jörg Reichrath
Journal:  Dermatoendocrinol       Date:  2011-01

4.  The Cdx-2 polymorphism in the VDR gene is associated with increased risk of cancer: a meta-analysis.

Authors:  Jin Huang; Jichong Huang; Yaxian Ma; Haichuan Wang; Jiqiao Yang; Tianyuan Xiong; Liang Du
Journal:  Mol Biol Rep       Date:  2013-05-07       Impact factor: 2.316

5.  Colloquium paper: human skin pigmentation as an adaptation to UV radiation.

Authors:  Nina G Jablonski; George Chaplin
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-05       Impact factor: 11.205

6.  Sun exposure, vitamin D receptor polymorphisms FokI and BsmI and risk of multiple primary melanoma.

Authors:  Rochelle Mandelcorn-Monson; Loraine Marrett; Anne Kricker; Bruce K Armstrong; Irene Orlow; Chris Goumas; Susan Paine; Stefano Rosso; Nancy Thomas; Robert C Millikan; Jason D Pole; Javier Cotignola; Cheryl Rosen; Peter A Kanetsky; Julia Lee-Taylor; Colin B Begg; Marianne Berwick
Journal:  Cancer Epidemiol       Date:  2011-05-25       Impact factor: 2.984

Review 7.  Targeting the vitamin D endocrine system (VDES) for the management of inflammatory and malignant skin diseases: An historical view and outlook.

Authors:  Jörg Reichrath; Christos C Zouboulis; Thomas Vogt; Michael F Holick
Journal:  Rev Endocr Metab Disord       Date:  2016-09       Impact factor: 6.514

8.  Vitamin D receptor gene polymorphisms, serum 25-hydroxyvitamin D levels, and melanoma: UK case-control comparisons and a meta-analysis of published VDR data.

Authors:  Juliette A Randerson-Moor; John C Taylor; Faye Elliott; Yu-Mei Chang; Samantha Beswick; Kairen Kukalizch; Paul Affleck; Susan Leake; Sue Haynes; Birute Karpavicius; Jerry Marsden; Edwina Gerry; Linda Bale; Chandra Bertram; Helen Field; Julian H Barth; Isabel Dos Santos Silva; Anthony Swerdlow; Peter A Kanetsky; Jennifer H Barrett; D Timothy Bishop; Julia A Newton Bishop
Journal:  Eur J Cancer       Date:  2009-07-15       Impact factor: 9.162

Review 9.  The Role of Classical and Novel Forms of Vitamin D in the Pathogenesis and Progression of Nonmelanoma Skin Cancers.

Authors:  Andrzej T Slominski; Anna A Brożyna; Michal A Zmijewski; Zorica Janjetovic; Tae-Kang Kim; Radomir M Slominski; Robert C Tuckey; Rebecca S Mason; Anton M Jetten; Purushotham Guroji; Jörg Reichrath; Craig Elmets; Mohammad Athar
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

10.  Association of vitamin D receptor gene variants, adiposity and colon cancer.

Authors:  Heather M Ochs-Balcom; Mine S Cicek; Cheryl L Thompson; Thomas C Tucker; Robert C Elston; Sarah J Plummer; Graham Casey; Li Li
Journal:  Carcinogenesis       Date:  2008-07-14       Impact factor: 4.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.